NEWS & EVENTS
A research team including NIBIB-funded scientists isolated circulating tumor cells (CTCs) in a mouse model of pancreatic cancer. Molecular analysis of the CTCs revealed distinct patterns of gene expression that were different from the primary pancreatic tumor. The surprising results identify potential new molecular targets that could lead to improved treatments for this deadly cancer. Read more in Bioscience Technology
Case Western Reserve University’s synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from NIBIB. Read more at News Medical.
A third of patients who undergo surgery to remove cancerous tumors end up with microscopic pieces left behind. These overlooked remnants can lead to the recurrence of cancer after what was thought to be a successful surgery. Two surgeons at the University of Pennsylvania have joined forces to try to solve this problem. Read more at philly.com
NIBIB Director Roderic Pettigrew discusses the recent spinal stimulation breakthrough for paralysis, other NIH-supported technologies for assisting individuals with paralysis or movement disorders, and future research directions in the Robert Wood Johnson Foundation's Human Capital blog. You can read the full post at www.rwjf.org.
An NIBIB-funded study at the University of Michigan seeks to make low-dose computed tomography scans a viable screening technique by speeding up the image reconstruction from half an hour or more to just five minutes.The advance could be particularly important for fighting lung cancers, as symptoms often appear too late for effective treatment. Read more and watch a video about the research in the University of Michigan press release.
NIBIB-supported biomedical engineer Sangeeta Bhatia has won the $500,000 Lemelson-MIT Prize in recognition of her work in designing and commercializing miniaturized technologies that seek to improve human health. Examples include developing a way to detect cancer through a paper urine test and building a microliver from scratch that can be used to help fight infectious diseases. Read the full story at BostonGlobe.com. Additional information can be found in the press release at lemeslson.mit.edu.
Researchers from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. Read more at UC Davis
A microfluidic device developed at Massachusetts General Hospital (MGH) may help study key steps in the process by which cancer cells break off from a primary tumor to invade other tissues and form metastases.